Stocks
CareDx, IncCDNA
NASDAQHealthcareBiotechnology$17.01+3.40%
Focused on molecular diagnostics for transplant patients, the company develops blood-based tests used to monitor organ rejection and guide post‑transplant care. Its flagship products, including AlloSure and AlloMap, are used by transplant centers to assess graft health without invasive biopsies. Inv...
Market Cap: $874.9M52W Range: $10.96 – $21.48
Congressional Interest in CareDx, Inc (CDNA)
2 members of Congress have disclosed 14 trades in CareDx, Inc (CDNA), a Healthcare company. The buy/sell breakdown shows 6 purchases versus 8 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
14
Unique Politicians
2
Buys
6
Sells
8
Who in Congress Is Trading CDNA?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-03-06 | Daniel Goldman | sell | $1K – $15K |
| 2021-03-02 | Tom Malinowski | buy | $15K – $50K |